Akili, Inc. (AKLI)
Jul 2, 2024 - AKLI was delisted (reason: acquired by Virtual Therapeutics)
0.433
+0.001 (0.25%)
Inactive · Last trade price on Jul 1, 2024

Akili Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year Ending
TTM Dec '23 Dec '22 Dec '21 Dec '20
Net Income
-48.55-59.49-19.04-126.66-25.65
Depreciation & Amortization
0.960.990.80.280.3
Share-Based Compensation
5.356.819.314.912.9
Other Operating Activities
-6.53-6.18-85.662.17-2.1
Operating Cash Flow
-48.77-57.87-83.52-53.98-24.55
Capital Expenditures
-0.37-0.14-0.04-0.49-0.12
Change in Investments
30.6483.56-81.1700
Investing Cash Flow
30.2783.41-81.22-0.49-0.12
Share Issuance / Repurchase
00131.960.260.02
Debt Issued / Paid
-6.25-4.38102.91.98
Other Financing Activities
-0.09-0.12-0.03109.68-
Financing Cash Flow
-6.34-4.49141.94112.852
Net Cash Flow
-24.8321.05-22.858.37-22.67
Free Cash Flow
-49.14-58.01-83.56-54.47-24.67
Free Cash Flow Margin
-2522.33%-3457.09%-25870.90%-10125.28%-626.22%
Free Cash Flow Per Share
-0.63-0.74-2.80-39.52-21.35
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).